A recent decision by the US Supreme Court may lead to increased legal action within the healthcare sector, says one expert. Federal Trade Commission deputy assistant director Sara Razi suggested that the Court’s decision, made last February, strengthened federal antitrust lawyers when clarifying when state antitrust law can trump federal; the Court unanimously agreed that “state-action immunity is disfavored” in FTC vs. Phoebe Putney Health System. The FTC sued the health group over a merger, approved by Georgia’s state hospital regulators. According to Razi, the ruling was “manna from heaven” and suggested that the Court’s ruling demonstrated unity between liberals and conservatives when it comes to federal antitrust exemptions. According to Razi, this may lead to more legal action taken within the healthcare sector as federals find the support of Supreme Court precedence.
Featured News
New York Puts Businesses on Notice for Algorithmic Pricing
Mar 19, 2026 by
CPI
Herbert Smith Freehills Kramer Expands US Antitrust Team with New Partner Hire
Mar 19, 2026 by
CPI
Mexico Antitrust Authority Fines Oxygen Suppliers Over Exclusive Contracts
Mar 19, 2026 by
CPI
EU Cloud Group Pushes for Halt to Broadcom VMware Changes
Mar 19, 2026 by
CPI
Sen. Blackburn Releases Discussion Draft of Bill to Set Federal ‘Framework’ for AI Policy
Mar 19, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Data-Driven Competition
Mar 19, 2026 by
CPI
Data-Driven Competition: Implications For Enforcement and Merger Control
Mar 19, 2026 by
Alexandre de Corniere & Greg Taylor
From Tipping to Trustees: Why Data-Driven Markets Require Institutional Design, Not Optimization
Mar 19, 2026 by
Jens Prüfer & Paul de Bijl
Data Barriers to Entry: What We’ve Learned About Spotting Them and What We Still Don’t Know About Solutions
Mar 19, 2026 by
Bruno Carballa-Smichowski
When the Perfect Is the Enemy of the Good: Price Discrimination, Affordability, Precarity and Market Dynamism
Mar 19, 2026 by
Dan Ciuriak